August 29, 2014 — MedAxiom Consulting announced the release of its 2014 Provider Compensation & Productivity Report, based on 2013 data submitted by 134 cardiology programs representing 2,554 cardiologists across the country. Of these responding groups, 97 of them are integrated and 37 remain private.

A research study published in the July issue Journal of the American College of Cardiology reports that genetic mutations in a neuronal sodium channel gene are associated with inherited sudden cardiac death syndromes, including the Brugada syndrome.

Tony Parris has worked for banks and electronics companies and has even driven an 18-wheel truck 995 miles a day for more than nine years as part of his working career. The 57-year-old Anniston native finally went into business for himself when he opened his own hardware store in Alexandria in 2010.

CMS announced the Open Payments system is once again available for physicians and teaching hospitals to register, review and, as needed, dispute financial payment information received from healthcare manufacturers. The system was taken offline on Aug. 3 to resolve a technical issue. To account for system downtime, CMS is extending the time for physicians and teaching hospitals to review their records to Sept. 8, 2014. The public website will be available on Sept. 30, 2014.

 

Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien study published online today in the Journal of American College of Cardiology, Cardiovascular Interventions (JACC CI). 

August 28, 2014 — The University of Michigan Frankel Cardiovascular Center is the first heart center in the nation to perform percutaneous implantation of the Edwards Sapien valve to replace a patient’s tricuspid valve.

August 28, 2014 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with heart failure or atrioventricular (AV) block.


August 28, 2014 — Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials, according to new recommendations published online in Catheterization and Cardiovascular Interventions by the Society for Cardiovascular Angiography and Interventions (SCAI).
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now